about
Targeted therapy in gastric cancer.Programmed death-ligand 1 expression in rectal cancer.Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.External validation of the NUn score for predicting anastomotic leakage after oesophageal resection.Targeting HER 2 and angiogenesis in gastric cancer.Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis.Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal CancerExpression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer.Radiofrequency ablation in patients with large cervical heterotopic gastric mucosa and globus sensation: Closing the treatment gap.Dysphagia severity is related to the amplitude of distal contractile integral in patients with Jackhammer esophagus.The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction.MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas.Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors.FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancerSimultaneous Pancreas-Kidney Transplantation Nine Years After Liver Transplantation—A Case ReportPD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaSarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinomaHigh Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal AdenocarcinomaPodoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagusStromal expression of carbonic anhydrase IX in esophageal cancerExpression of FGF8, FGF18, and FGFR4 in Gastroesophageal AdenocarcinomasElectrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility-a safety and efficacy studySystemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing ResectionHigh Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal AdenocarcinomaModern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients
P50
Q37341824-75C7BFEF-A828-4726-B519-8F1B62581388Q37515182-33F987B5-A1A5-4C5F-A648-F15B82C9279EQ37688471-2C233CD5-4CE3-4AF5-A137-A8C887735BAAQ38602997-1A99CF55-D2EF-4A70-9D7B-AD3607DCC4ECQ38633308-F049152B-3B3B-4077-8309-1B4766C3A2EDQ39580126-4737CBEA-0A66-4D12-81BB-9F86DC4C1D2EQ40979708-A54C259B-27E9-434D-A51E-61009AF886AFQ41204382-9DBA36EE-A47A-4047-8A35-5A90D0C66FDAQ43235390-02D3B137-8F93-4376-A332-F45C550EFF07Q43494045-CF0B1DE1-2D2E-446E-A707-612A24B07C95Q47627002-69EEF4C8-898E-4917-B62F-035C42C078B6Q48367177-E2D0A4F1-2AD5-4329-82C9-35D6BF62A582Q50281305-5633439E-1891-4C3E-82D9-A6A23D74BB11Q50333545-316BA1A2-F6F3-4E0A-BCF1-0BA7A1B1DDD5Q55517437-F2BE6B7B-3EF7-482C-8FC7-70667C172AB4Q57056933-F9FCDDA2-B9C5-4045-AE69-FE912C1013E7Q62517893-71C59AD0-B824-44A9-9A2C-AFCE1D35BEEAQ62888577-0BE0BEA1-521C-417F-A250-52ECD0DFAE98Q64065923-C8709461-F22A-480E-A3D7-732FD3D692B4Q64236861-C53FC35F-4DF2-498D-9525-4E73C867B30BQ85475870-5C1DD879-8344-46D6-8C9A-A3CEB392FE27Q87690590-E71B7E9D-5319-439A-909D-1DDEA6B5A346Q90133622-C0DCBD10-DD34-4BE0-9E5E-38E1B853944BQ91172389-0049C107-1E53-47FF-88A3-EAE2BB9647B9Q92691858-D0F38F02-89E0-4291-B892-30C85A887904Q92696309-92275D27-FE43-4E7A-B164-238DF5AB30B8Q92764018-90C1A349-8E9B-45C0-AD3B-D8248869B9EB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
G Jomrich
@ast
G Jomrich
@en
G Jomrich
@es
G Jomrich
@nl
type
label
G Jomrich
@ast
G Jomrich
@en
G Jomrich
@es
G Jomrich
@nl
prefLabel
G Jomrich
@ast
G Jomrich
@en
G Jomrich
@es
G Jomrich
@nl
P106
P31
P496
0000-0002-7294-4831